← Back
$SRPT All transactions

Sarepta Therapeutics, Inc.

A

$ Value

$0

Shares

25,000

Price

$0

Filed

Sep 5

Insider

Name

Rothfuss Cristin

Title

EVP, General Counsel

CIK

0002046214

Roles

Officer

Transaction Details

Transaction Date

2025-09-03

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

139,985

Footnotes

The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company. | The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board.

Filing Info

Accession No.

0001193125-25-197422

Form Type

4

Issuer CIK

0000873303

Rothfuss Cristin's History

Date Ticker Type Value
2025-11-28 SRPT F $5K
2025-09-03 SRPT A $0
2025-09-03 SRPT A $0

Other Insiders at SRPT (90d)

No other insider activity at this issuer in the last 90 days.